Optimizing Analytical Methods to Guarantee Safe, High Quality,
Consistent & Efficacious Gene Therapy Products

In the context of rapid gene therapy progress and mounting regulatory scrutiny, the 2nd Annual
Gene Therapy Analytical Development Summit will virtually unite large pharma and innovative biotechs to discuss the full and comprehensive range of analytical tools required to guarantee the consistency, quality and safety of gene therapy products.

Focused specifically on addressing the unique analytical challenges posed by gene therapy vectors, this technical scientific conference will unite the Analytical Development, QC, CMC, and Process Development leaders grappling with these challenges first-hand.

Incorporating tracks taking a deep dive into bioassays, molecular biology, and analytical chemistry, this is your opportunity to gain extensive technical information enabling you to solve the exact challenges you’re encountering. Enhance your existing analytical methods and explore innovative novel tools to support safe and effective gene therapy development.

Download the full event guide for more information.

World-Class Speaking Faculty

Claire Davies

Head of Bioanalytics

Sanofi

Fengrong Zuo

Senior Director, Analytical Development Department, CMC Regulatory, Quality & Analytical Development

AveXis

Joseph Lee

Executive Director, Analytical Development, Gene Therapy

PTC Therapeutics

Mark Galbraith

Head of Quality Control & Analytical Sciences

Spark Therapeutics

Barbara Bonamassa

Quality Assessor & European Medicines Agency (EMA) Expert for ATMPs

Italian Medicines Agency (AIFA)

Gael Debauve

Head of Gene Therapy CMC Analytics

UCB

Marina Feschenko

Director, Analytical Development

Biogen

Uditha deAlwis

Executive Director, Analytical Sciences

Sarepta Therapeutics

Other Events in the Gene Therapy Series